Exactly, they need to sell this company more. There’s a reason that dog stocks with zero revenue are often valued so high, because those companies can sell the story. Nova Eye is clearly determined to be a leading ophthalmology company with a large range of highly innovative products, they need to sell that vision to the market. They’ve done great so far executing on that vision, now it is time to generate the much needed awareness so that investors can actually find this gem.
Exactly, they need to sell this company more. There’s a reason...
-
- There are more pages in this discussion • 1,633 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.010(5.56%) |
Mkt cap ! $43.52M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.5¢ | 18.5¢ | $12.62K | 66.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 49388 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 63159 | 2 |
View Market Depth
| Last trade - 12.20pm 18/10/2024 (20 minute delay) ? |
| EYE (ASX) Chart |